17-18121940-C-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_016239.4(MYO15A):​c.3140C>G​(p.Pro1047Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00405 in 1,613,412 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1047H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0072 ( 9 hom., cov: 33)
Exomes 𝑓: 0.0037 ( 20 hom. )

Consequence

MYO15A
NM_016239.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.701

Publications

9 publications found
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
MYO15A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0052706897).
BP6
Variant 17-18121940-C-G is Benign according to our data. Variant chr17-18121940-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 226783.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00716 (1090/152274) while in subpopulation AFR AF = 0.0163 (677/41560). AF 95% confidence interval is 0.0153. There are 9 homozygotes in GnomAd4. There are 529 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO15ANM_016239.4 linkc.3140C>G p.Pro1047Arg missense_variant Exon 2 of 66 ENST00000647165.2 NP_057323.3 Q9UKN7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkc.3140C>G p.Pro1047Arg missense_variant Exon 2 of 66 NM_016239.4 ENSP00000495481.1 Q9UKN7-1
MYO15AENST00000583079.1 linkn.2773C>G non_coding_transcript_exon_variant Exon 1 of 1 6

Frequencies

GnomAD3 genomes
AF:
0.00699
AC:
1063
AN:
152156
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00232
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00447
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00353
AC:
879
AN:
249180
AF XY:
0.00347
show subpopulations
Gnomad AFR exome
AF:
0.0158
Gnomad AMR exome
AF:
0.00151
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.000890
Gnomad FIN exome
AF:
0.00153
Gnomad NFE exome
AF:
0.00367
Gnomad OTH exome
AF:
0.00298
GnomAD4 exome
AF:
0.00373
AC:
5451
AN:
1461138
Hom.:
20
Cov.:
44
AF XY:
0.00373
AC XY:
2710
AN XY:
726868
show subpopulations
African (AFR)
AF:
0.0167
AC:
559
AN:
33480
American (AMR)
AF:
0.00148
AC:
66
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.000806
AC:
32
AN:
39698
South Asian (SAS)
AF:
0.00337
AC:
291
AN:
86258
European-Finnish (FIN)
AF:
0.00167
AC:
88
AN:
52722
Middle Eastern (MID)
AF:
0.00659
AC:
38
AN:
5768
European-Non Finnish (NFE)
AF:
0.00370
AC:
4116
AN:
1111972
Other (OTH)
AF:
0.00427
AC:
258
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
399
799
1198
1598
1997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00716
AC:
1090
AN:
152274
Hom.:
9
Cov.:
33
AF XY:
0.00711
AC XY:
529
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0163
AC:
677
AN:
41560
American (AMR)
AF:
0.00274
AC:
42
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00232
AC:
12
AN:
5170
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4832
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00447
AC:
304
AN:
67996
Other (OTH)
AF:
0.0114
AC:
24
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
57
113
170
226
283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00170
Hom.:
0
Bravo
AF:
0.00743
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.0152
AC:
60
ESP6500EA
AF:
0.00432
AC:
36
ExAC
AF:
0.00386
AC:
467
Asia WGS
AF:
0.0180
AC:
64
AN:
3478
EpiCase
AF:
0.00387
EpiControl
AF:
0.00367

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not specified Benign:1
Apr 21, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Pro1047Arg in exon 2 of MYO15A: This variant is not expected to have clinical significance because it has been identified in 1.6% (159/9738) of European chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs77565048). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
11
DANN
Benign
0.78
DEOGEN2
Benign
0.011
T;T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.35
T;.;T
MetaRNN
Benign
0.0053
T;T;T
MetaSVM
Benign
-0.77
T
MutationAssessor
Benign
0.97
.;L;L
PhyloP100
0.70
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.70
.;N;.
REVEL
Benign
0.15
Sift
Uncertain
0.0020
.;D;.
Sift4G
Uncertain
0.0090
D;D;.
Polyphen
0.23
.;B;B
Vest4
0.15
MVP
0.45
ClinPred
0.028
T
GERP RS
2.5
Varity_R
0.054
gMVP
0.28
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77565048; hg19: chr17-18025254; API